Anticholinergic action of cholinesterase reactivator methoxime (bis-/4-hydroxyaminomethylpyridinium/-methane dichloride).
D000818:Animals; D001285:Atropine / Q000627:therapeutic use; D002801:Cholinesterase Reactivators / Q000627:therapeutic use*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D062025:Organophosphate Poisoning; D063086:Organothiophosphates; D010091:Oximes / Q000627:therapeutic use*; D012119:Respiration / Q000187:drug effects; D013997:Time Factors
D002801:Cholinesterase Reactivators; D063086:Organothiophosphates; D010091:Oximes; C010400:O-ethyl S-(2-dimethylaminoethyl) methylphosphonothioate; C005514:N,N'-monomethylenebis(pyridiniumaldoxime); D001285:Atropine